Primary record
3H-1,2,4-Triazol-3-one, 5-[[(2R,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-; (R,R,R)-Aprepitant; Aprepitant Related Compound A (USP); Aprepitant Related Compound A
- 库存
- 3,851 克
- 纯度
- 99.7 %
- CAS
- 1148113-53-4
化合物标识与属性
- CAS
- 1148113-53-4
- PubChem CID
- 135925275
- SMILES
- C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@H](N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F
- Canonical SMILES
- C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1
名称与同义词
- (R,R,R)-Aprepitant
- (1R,2R,3R)-Aprepitant
- Aprepitant Impurity 1
- 1148113-53-4
- 1R,2R,2R Aprepitant
- HCY48YN9FC
- Aprepitant, (R,R,R)-
- Aprepitant Related Compound A
- C23H21F7N4O3
- MFCD23704633
- CHEMBL3349013
- DTXSID40676985
- ATALOFNDEOCMKK-TVNIXMEMSA-N
- ZINC52245742
- AKOS025149371
- AKOS037645094
- ACN-047979
- FA17961
- NCGC00181785-01
- AS-57054
- SY332682
- J2.660.218A
- KS-00000262
- Aprepitant Impurity J; Fosaprepitant Impurity E
- W19477
- A898949
- 3-[[(2R,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one
- B2694-466699
- 3-(((2R,3R)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-1H-1,2,4-triazol-5(4H)-one
- 5-(((2R,3R)-2-((R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-3-(4-FLUOROPHENYL)MORPHOLINO)METHYL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE
- 170729-80-3
- 5-[[(2R,3R)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one
- 5-[2(R)-[1(R)-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY]-3(S)-(4-FLUOROPHENYL)MORPHOLIN-4-YLMETHYL]-3,4-DIHYDRO-2H-1,2,4-TRIAZOL-3-ONE
- 3-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one
- 3-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one ((R,R,R)-Aprepitant)
- 3-[[2alpha-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3beta-(4-fluorophenyl)morpholine-4-yl]methyl]-1H-1,2,4-triazole-5(4H)-one
- 3-[2alpha-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3beta-(4-fluorophenyl)morpholine-4-ylmethyl]-1H-1,2,4-triazole-5(4H)-one
- 3-{[(2R,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-4,5-dihydro-1H-1,2,4-triazol-5-one
- 3H-1,2,4-Triazol-3-one, 5-[[(2R,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-
- 3H-1,2,4-Triazol-3-one, 5-[[(2R,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-; (R,R,R)-Aprepitant; Aprepitant Related Compound A (USP); Aprepitant Related Compound A
- 5-[[(2R,3R)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihyd
- 5-[[(2R,3R)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol- 3-one
- 5-[[(2R,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
- 5-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-2,4-dihydro-3H-1,2,4-triazole-3-one
- 5-{[(2R,3R)-2-{(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-1,2-dihydro-3H-1,2,4-triazol-3-one